R&D spending rose in response to COVID-19, bringing with it higher expectations for returns on all biopharma investments. The once sky-high projections are coming down to Earth, with returns now in line with pre-pandemic levels, according to a new Del
Partner's problematic behavior gets the attention of firm leaders. The post Biglaw Firm Investigating Partner’s Alleged Bullying appeared first on Above the Law.
Is your firm as dedicated to making employee health and wellness a priority? The post This Biglaw Firm Is Using Its Robust Wellness Programs As A Recruiting Tool appeared first on Above the Law.
'I think the hesitancy on our side would be - well, so soon after creating the Space Force, we don’t want to just create a bunch of bureaucracy,' Rep. Mike Gallagher, R-Wisc., said. The post Lawmaker ‘Definitely’ Considering Value Of Independent Cyber For